JOHNSON + JOHNSON DL 1 | 139.10 / -0.64% |
News
- Wall Street closes with losses as Fed, earnings loom
01/30/2023 / 22:01 - TeleTrader - J&J to challenge bankruptcy ruling
01/30/2023 / 19:40 - TeleTrader - J&J talc unit's bankruptcy petition in US dismissed
01/30/2023 / 17:51 - TeleTrader - J&J's Q4 sales down 4.4% to $24B on lower COVID-19 vaccine sales
01/24/2023 / 12:27 - TeleTrader - J&J reportedly cuts COVID vaccine production
01/13/2023 / 17:14 - TeleTrader - Abiomed skyrockets 50% on J&J's takeover deal
11/01/2022 / 17:46 - TeleTrader - J&J to reduce headcount despite robust sales
10/18/2022 / 18:29 - TeleTrader - J&J's Q3 sales up 1.9% to $23.8 billion
10/18/2022 / 12:27 - TeleTrader - J&J launches $5B share buyback program
09/14/2022 / 12:48 - TeleTrader - J&J to stop selling talc-based baby powder in 2023
08/12/2022 / 00:54 - TeleTrader - J&J posts Q2 EPS of $1.8, dropping 23.4% YoY
07/19/2022 / 12:26 - TeleTrader - FDA limits J&J vaccine use due to blood clot risks
05/06/2022 / 02:58 - TeleTrader - J&J's Q1 sales up 5% YoY to $23.4B
04/19/2022 / 12:27 - TeleTrader - CDC confirms additional boosters for over-50s
03/29/2022 / 22:41 - TeleTrader - Johnson: Putin must know he would pay high price for invasion
02/19/2022 / 11:37 - TeleTrader